Loss of NF1 also occurs in 5% of all sporadic tumors, including glioblastoma multiforme (GBM), breast cancer, endometrial cancer, ovarian cancer, both melanoma and non-melanoma skin cancers, and lung cancer (Philpott et al., 2017). Here, NF1 is linked to lung carcinoma.